CORDIS · 232545 · FP7
BRAINSAFE Development of a new, non invasive absolute Intracranial Pressure (aICP) measurement device based on ultrasound and Doppler technologies
Coordinator: UAB Vittamed (LT)
Only invasive technologies only for diagnostics of Intracranial Pressure (ICP) for patients with severe Traumatic Brain Injury (TBI) are available today. The procedure requires neurosurgeon to place the catheter inside the patient´s skull that exposes the patients to the risk of infection (5%), bleeding, leak of fluids or loss of other body tissue, pain, hyperthermia as well as risks related to anaesthetics. Relative to these risks and complexity of the procedure, only 20% of all TBI patients get access to the diagnostics of ICP, leaving out 1,280,000 TBI patients without proper examination o…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €896k awarded to the consortium. The project runs over approximately 2 years from 2009-10-01 to 2011-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from LT
see all →- SustAInLivWork — Centre of Excellence of AI for Sustainable Living and Working101059903 · HORIZON · €14.7M
- SUPER PV — CoSt redUction and enhanced PERformance of PV systems792245 · H2020 · €9.9M
- Forest 4.0 — Creation of the centre of excellence in smart forestry101059985 · HORIZON · €9.9M
- FemtoSurf — Functional surface treatments using ultra-short pulse laser system FemtoSurf825512 · H2020 · €7.0M
- GIFFT — Sustainable Glass Industry with Fuel-Flexible Technology101122257 · HORIZON · €4.5M
- EnergyKeeper — Keep the Energy at the right place!731239 · H2020 · €4.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the BSG-SME funding scheme.
- What is the EU contribution?
- The European Commission contributes €896k.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by UAB Vittamed (LT).
- What is the project timeline?
- The project runs from 2009-10-01 to 2011-09-30 — approximately 2 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 232545.